Last Seen Blogs
littlelightfish
SmolMonkfish
revelyeol
y yo a ti, cas
goldenmadam
BTS | Genshin Impact
hiimsensei
see you space fuccboi...
Text
As per the report from nova one advisor, the global Active Pharmaceutical Ingredients market size was exhibited at USD 236.07 billion in 2023 and is projected to hit around USD 395.8 billion by 2032, growing at a CAGR of 5.91% during the forecast period 2023 to 2032.
0 notes
Text
The global next generation sequencing market size was valued at USD 11.19 billion in 2024 and is anticipated to reach around USD 66.04 billion by 2033, growing at a CAGR of 21.8% from 2024 to 2033.
0 notes
Text
According to the latest research by nova one advisor, the global construction equipment market size was exhibited at USD 198.97 billion in 2023 and is projected to hit around USD 411.19 billion by 2032, growing at a CAGR of 8.4% during the forecast period 2023 to 2032.
0 notes
Text
According to a new report by Precedence Research, the global moisture analyzer market size was valued at USD 1.91 billion in 2023 and is projected to reach USD 3.42 billion by 2033, growing at a CAGR of 6% from 2024 to 2033
0 notes
Text
The global modular construction market size was exhibited at USD 97.3 billion in 2023 and is projected to hit around USD 201.31 billion by 2033, growing at a CAGR of 7.54% during the forecast period 2024 to 2033.
0 notes
Text
The U.S. influenza diagnostics market size was estimated at USD 199.90 million in 2023 and is expected to surpass around USD 329.04 million by 2033 and poised to grow at a compound annual growth rate (CAGR) of 5.11% during the forecast period 2024 to 2033.
0 notes
Text
The U.S. pharmaceutical analytical testing outsourcing market size was exhibited at USD 4.50 billion in 2023 and is projected to hit around USD 9.07 billion by 2032, growing at a CAGR of 8.1% during the forecast period 2023 to 2032.
0 notes
Text
The global cell and gene therapy manufacturing market size was evaluated at USD 9.95 billion in 2023 and is expected to attain around USD 106.03 billion by 2033, growing at a CAGR of 26.7% from 2024 to 2033.North America accounted for the highest revenue share of 48.32% in 2023.
0 notes
Text
The global oncology clinical trials market size was valued at USD 13.19 billion in 2023 and is projected to reach USD 22.11 Billion by 2033, growing at a CAGR of 5.3 % from 2024 to 2033.
0 notes
Text
According to the latest research by nova one advisor the global biological safety testing products and services market sizev was estimated at USD 4.85 billion in 2023 and is projected to hit around USD 13.53 billion by 2033, growing at a CAGR of 10.8% during the forecast period from 2024 to 2033
0 notes
Text
In the rapidly growing field of the global next generation sequencing market size was valued at USD 9.19 billion in 2023 and is projected to reach USD 66.04 billion by 2033, growing at a CAGR of 21.8% from 2024 to 2033 according to a new report by Nova One Advisor.
0 notes
Text
According to the latest research by Nova One Advisor, the global biotechnology market size was valued at USD 1.54 Trillion in 2023 and is projected to reach USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% from 2024 to 2033
0 notes
Text
The global single cell genome sequencing market size was exhibited at USD 3.31 billion in 2023 and is projected to hit around USD 12.79 billion by 2032, growing at a healthy CAGR of 16.2% from 2023 to 2032.
1 note
·
View note
Text
According to the latest research by nova one advisor, the global biopharmaceuticals contract manufacturing market size was exhibited at USD 19.89 billion in 2023 and is projected to hit around USD 31.92 billion by 2032, growing at a CAGR of 5.4% during the forecast period 2023 to 2032.
0 notes
Text
According to latest study, the global advanced therapy medicinal products CDMO Market size was valued at USD 6.10 billion in 2023 and is projected to reach USD 34.53 billion by 2033, growing at a CAGR of 18.93% from 2024 to 2033.
0 notes
Text
The global cell and gene therapy CDMO Market size was valued at USD 5.90 billion in 2023 and is projected to reach USD 69.11 billion by 2033, growing at a CAGR of 27.9% from 2024 to 2033 according to a new report by Nova One Advisor.
0 notes
Text
The non-steroidal anti-inflammatory drugs market size was estimated at USD 21,207.15 million in 2022 and is expected to surpass around USD 35,780.96 million by 2032 and poised to grow at a compound annual growth rate (CAGR) of 5.37% during the forecast period 2023 to 2032.
0 notes